AD and ALS patients exhibit increased levels of NF-L protein in their CSF as verified using ELISA, from about ~ 2.5–15-fold over age-matched controls, thus providing a peripheral biofluid indicator of axonal damage and neuronal cell demise. Here, NEFL is linked to Alzheimer disease.